` DEL (Delorean Corporation Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

DEL
vs
S
S&P/ASX 300

Over the past 12 months, DEL has underperformed S&P/ASX 300, delivering a return of -33% compared to the S&P/ASX 300's +4% growth.

Stocks Performance
DEL vs S&P/ASX 300

Loading
DEL
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
DEL vs S&P/ASX 300

Loading
DEL
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
DEL vs S&P/ASX 300

Loading
DEL
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Delorean Corporation Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Delorean Corporation Ltd
Glance View

Market Cap
20m AUD
Industry
Utilities

Delorean Corp. Ltd. is an Australian bioenergy company. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-04-12. The firm is specialized in the designing, building, ownership, and management of bioenergy infrastructure and associated power generation and retail. The company offers bioenergy infrastructure and asset development services, anaerobic digestion plant construction and operation, stainless steel tank, and pipework fabrication and retailing of electricity. The Company’s projects include Jandakot Bioenergy Plant, Blue Lake Milling Bioenergy Plant, Ecogas Bioenergy Project, Delorean Energy SA One Project, Delorean Energy Victoria One Project, Delorean Energy Queensland One Project, and Delorean Energy Victoria Two Project.

DEL Intrinsic Value
0.088 AUD
Overvaluation 3%
Intrinsic Value
Price
Back to Top